Replies to post #368803 on Amarin Corp Plc (AMRN)

[tke458]

May be their way to set up approval for only the secondary….

[sts66]

Therefore, it would be appropriate for the company to only provide additional analyses and information for the secondary prevention subgroup

.

WTF? Shouldn't that have been the main info provided, since secondary prevention was a PE and primary prevention was an SE? How could AMRN NOT have provided them this info?

The committee concluded that given the uncertainty and the company’s base case ICERs, icosapent ethyl could not be recommended for any of the populations considered."

Costs too much money even in the secondary prevention group, but they claim they don't have enough info to evaluate it for that use? Who the hell are these people - and why is their ICER analysis so far off from the US's, $20k/QYLD vs $50k?

[TOSCA]

To direct queries...

[e-mail].......link

https://www.evidence.nhs.uk/document?id=2399612&returnUrl=search%3fpa%3d1%26q%3draised%2btriglycerides